Table 1 Baseline characteristics

From: Role of malaria exposure and off-target responses on RTS,S/AS02A vaccine immunogenicity and protection in Mozambican children

 

Cohort 1: Manhiça

Cohort 2: Ilha Josina

All subjects

N

743 (85.08%)

131 (14.92%)

874 (100%)

Treatment

 Comparator

68 (9.15%)

67 (51.15%)

135 (15.45%)

 RTS,S

675 (90.85%)

64 (48.85%)

739 (84.55%)

Sex (female)

346 (46.57%)

70 (53.44%)

416 (47.60%)

Age

 12 < 24 months

174 (23.42%)

40 (30.53%)

214 (24.49%)

 Median [Q1, Q3]

17.50 [12.27, 23.92]

19.08 [12.27, 23.62]

17.70 [12.27, 23.92]

 24 < 59 months

569 (76.58%)

91 (69.47%)

660 (75.51%)

 Median [Q1, Q3]

40.66 [24.01, 59.84]

41.11 [24.15, 59.01]

40.99 [24.01, 59.84]